X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs SUN PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA SUN PHARMA SANOFI INDIA/
SUN PHARMA
 
P/E (TTM) x 35.1 32.5 108.1% View Chart
P/BV x 6.2 2.7 227.8% View Chart
Dividend Yield % 1.4 0.5 303.0%  

Financials

 SANOFI INDIA   SUN PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
SUN PHARMA
Mar-18
SANOFI INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,840701 976.5%   
Low Rs4,630433 1,068.8%   
Sales per share (Unadj.) Rs1,203.1110.4 1,089.7%  
Earnings per share (Unadj.) Rs165.311.0 1,505.5%  
Cash flow per share (Unadj.) Rs209.917.2 1,218.1%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.4 415.1%  
Book value per share (Unadj.) Rs963.6158.8 606.8%  
Shares outstanding (eoy) m23.032,399.26 1.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.85.1 92.8%   
Avg P/E ratio x34.751.6 67.2%  
P/CF ratio (eoy) x27.332.9 83.1%  
Price / Book Value ratio x6.03.6 166.7%  
Dividend payout %50.818.2 279.0%   
Avg Mkt Cap Rs m132,0781,360,021 9.7%   
No. of employees `0003.317.8 18.6%   
Total wages/salary Rs m4,06853,671 7.6%   
Avg. sales/employee Rs Th8,393.814,890.9 56.4%   
Avg. wages/employee Rs Th1,232.43,017.1 40.8%   
Avg. net profit/employee Rs Th1,153.01,480.6 77.9%   
INCOME DATA
Net Sales Rs m27,708264,895 10.5%  
Other income Rs m8978,388 10.7%   
Total revenues Rs m28,605273,282 10.5%   
Gross profit Rs m6,23556,081 11.1%  
Depreciation Rs m1,02714,998 6.8%   
Interest Rs m75,176 0.1%   
Profit before tax Rs m6,09844,295 13.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-9,505 0.0%   
Tax Rs m2,2928,452 27.1%   
Profit after tax Rs m3,80626,338 14.5%  
Gross profit margin %22.521.2 106.3%  
Effective tax rate %37.619.1 197.0%   
Net profit margin %13.79.9 138.2%  
BALANCE SHEET DATA
Current assets Rs m15,922316,359 5.0%   
Current liabilities Rs m6,235198,643 3.1%   
Net working cap to sales %35.044.4 78.7%  
Current ratio x2.61.6 160.3%  
Inventory Days Days6495 67.1%  
Debtors Days Days21108 19.4%  
Net fixed assets Rs m7,539213,178 3.5%   
Share capital Rs m2302,399 9.6%   
"Free" reserves Rs m21,962378,606 5.8%   
Net worth Rs m22,192381,006 5.8%   
Long term debt Rs m017,721 0.0%   
Total assets Rs m29,839643,028 4.6%  
Interest coverage x872.19.6 9,124.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.4 225.4%   
Return on assets %12.84.9 260.7%  
Return on equity %17.26.9 248.1%  
Return on capital %27.510.0 274.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58740,816 18.6%   
Fx outflow Rs m7,14530,143 23.7%   
Net fx Rs m44210,673 4.1%   
CASH FLOW
From Operations Rs m3,73939,072 9.6%  
From Investments Rs m-731-33,708 2.2%  
From Financial Activity Rs m-1,972-15,393 12.8%  
Net Cashflow Rs m1,036-7,359 -14.1%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 5.1 280.7%  
FIIs % 14.6 23.0 63.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 8.3 126.5%  
Shareholders   15,184 133,026 11.4%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 305 Points Lower; FMCG and Finance Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jul 22, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS